Global Biopharmaceutical Cmo And Cro Market Size & Outlook
Global biopharmaceutical cmo and cro market, 2017-2030 (US$M)
Related Markets
Global biopharmaceutical cmo and cro market highlights
- The global biopharmaceutical cmo and cro market generated a revenue of USD 29,412.5 million in 2021 and is expected to reach USD 54,121.6 million by 2030.
- The market is expected to grow at a CAGR (2022 - 2030) of 7% by 2030.
- In terms of segment, mammalian accounted for a revenue of USD 18,369.6 million in 2021.
- Mammalian is the most lucrative source segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2021.
- Country-wise, China is expected to register the highest CAGR from 2022 to 2030.
Global data book summary
| Market revenue in 2021 | USD 29,412.5 million |
| Market revenue in 2030 | USD 54,121.6 million |
| Growth rate | 7% (CAGR from 2021 to 2030) |
| Largest segment | Mammalian |
| Fastest growing segment | Mammalian |
| Historical data covered | 2017 - 2020 |
| Base year for estimation | 2021 |
| Forecast period covered | 2022 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Mammalian, Non-mammalian |
Other key industry trends
- In terms of revenue, the North America accounted for 34.0% of the global biopharmaceutical cmo and cro market in 2021.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, China is the fastest growing regional market and is projected to reach USD 4,885.7 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Biopharmaceutical CMO And CRO Market Scope
Biopharmaceutical CMO And CRO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global biopharmaceutical cmo and cro market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biopharmaceutical cmo and cro market will help companies and investors design strategic landscapes.
Mammalian was the largest segment with a revenue share of 62.46% in 2021. Horizon Databook has segmented the Global biopharmaceutical cmo and cro market based on mammalian, non-mammalian covering the revenue growth of each sub-segment from 2017 to 2030.
With improvement in outsourced services, biopharmaceuticals industry continues to show surge in number of biopharmaceutical firms opting for contract services. CMOs are making enormous sums of investments for expansion of their manufacturing capabilities. Smaller companies are also expanding their non-GMP facilities. For instance, Biotech pharma UAB installed a 200L single-use bioreactor in its non-GMP process development facility.
Many entities are also observed to add capacity through both internal expansions and acquisitions to fulfill the growing demand for such services. For instance, in December 2014, Fujifilm Diosynth biotechnologies acquired Texas-based Kalon Biotherapeutics with an aim to enhance its vaccine manufacturing capacity.
The company is also engaged in process and analytical development capabilities. As per survey of contract manufacturing organizations (CMOs), manufacturing capacities growing by 7%.The manufacturing capacity for contract manufacturing was estimated to hit 1 million liters in 2015.
Reasons to subscribe to Global biopharmaceutical cmo and cro market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global biopharmaceutical cmo and cro market databook
-
Our clientele includes a mix of biopharmaceutical cmo and cro market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global biopharmaceutical cmo and cro market , including forecasts for subscribers. This global databook contains high-level insights into Global biopharmaceutical cmo and cro market from 2017 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global biopharmaceutical cmo and cro market size, by regions, 2017-2030 (US$M)
Top 10 countries: Biopharmaceutical cmo and cro market size, 2021 (US$M)
Global biopharmaceutical cmo and cro market share, by source, 2021 & 2030 (%, US$M)
Biopharmaceutical cmo and cro market: Opportunity assessment by country
Global biopharmaceutical cmo and cro market, by region, 2021 (US$M)
| Source | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 6,988.3 | 7,718.1 | 8,443.1 | 9,205.5 | 9,991.3 | 10,997.9 | 11,988.4 | 12,917.0 | 13,790.1 | 14,786.3 | 15,627.2 | 16,471.2 | 17,318.6 | 18,169.3 | 6.9% |
| Europe | 6,328.7 | 6,991.7 | 7,650.7 | 8,414.2 | 9,073.9 | 9,976.7 | 11,105.4 | 11,907.6 | 12,650.4 | 13,497.4 | 14,194.4 | 14,886.9 | 15,575.1 | 16,258.9 | 6.7% |
| Asia Pacific | 5,823.2 | 6,494.3 | 7,173.7 | 8,476.7 | 9,244.4 | 10,229.4 | 11,532.4 | 12,356.5 | 13,115.2 | 13,977.9 | 14,680.0 | 15,375.7 | 16,064.7 | 16,747.2 | 6.8% |
| Latin America | 673.6 | 747.9 | 822.6 | 582.0 | 552.9 | 632.4 | 800.2 | 892.7 | 986.9 | 1,095.4 | 1,198.8 | 1,306.8 | 1,419.2 | 1,536.2 | 12.0% |
| MEA | 464.0 | 514.7 | 565.5 | 516.7 | 550.0 | 596.8 | 782.1 | 864.4 | 946.6 | 1,041.1 | 1,128.6 | 1,219.2 | 1,313.1 | 1,410.0 | 11.0% |
| Overall | 20,277.8 | 22,466.7 | 24,655.6 | 27,195.1 | 29,412.5 | 32,433.2 | 36,208.5 | 38,938.2 | 41,489.2 | 44,398.1 | 46,829.0 | 49,259.8 | 51,690.7 | 54,121.6 | 7.0% |
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
